12/1/2023
OSHA announces its preliminary finding to grant LabTest Certification Inc.'s application for expansion of recognition as a Nationally Recognized Testing Laboratory (NRTL).
12/1/2023
The Federal Unemployment Tax Act (FUTA) will experience credit reductions starting in 2023, affecting employers who fail to pay state unemployment taxes on time, according to a recent IRS notice.
11/30/2023
The European Patent Office (EPO) has announced that it will no longer charge page fees for ST.25 sequence listings submitted as part of divisional patent applications, effective immediately.
11/30/2023
The Bank of Korea's Monetary Policy Board decided to maintain the Base Rate at 3.50% for the intermeeting period, citing elevated inflation.
11/30/2023
The U.S. government has launched a website to assist candidates in the 2024 Presidential election with access to key information about the Federal Government structure and Presidential Transition policies, mandated by the Presidential Transition Act of 1963.
11/30/2023
The Business Standards Council is seeking public input on the annual update to the real property management business standards, which support Federal shared services, and will consider comments received until a specified date.
11/30/2023
The Office of the United States Trade Representative is providing notice of country-by-country reallocations of the fiscal year 2024 in-quota quantity of the World Trade Organization tariff-rate quota for imported raw cane sugar, following unused quantities.
11/30/2023
The FDA is proposing to require premarket approval for certain solid wound dressings, wound dressings with antimicrobial properties, and liquid wound washes containing high-risk antimicrobials, in an effort to reduce the risk of illness and injury.
11/30/2023
The FDA is proposing to reclassify certain types of wound dressings and liquid wound washes containing antimicrobials and/or other chemicals, including those with high levels of antimicrobial resistance, into new categories with varying levels of regulation.
11/30/2023
The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for ZEGALOGUE, a human drug product, in response to a patent extension application submitted to the US Patent and Trademark Office (USPTO).
11/30/2023
The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, as required by law.
11/30/2023
The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for Amondys 45, a human drug product, in response to patent extension applications submitted to the US Patent and Trademark Office (USPTO).
11/30/2023
The U.S. Food and Drug Administration (FDA) has determined the regulatory review period for Qelbree, a human drug product, following the submission of patent extension applications to the U.S. Patent and Trademark Office (USPTO).
11/30/2023
The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for Ukoniq, a human drug product, following submissions to the US Patent and Trademark Office (USPTO) for patent extension.
11/30/2023
The US Food and Drug Administration (FDA) has released a draft guidance document outlining how pet food manufacturers can use relative supersaturation (RSS) methodology to support claims that certain adult maintenance cat foods promote urinary tract health.
11/30/2023
The U.S. Food and Drug Administration (FDA) has published a notice determining the regulatory review period for Koselugo, a human drug product, following a patent extension application submitted to the U.S. Patent and Trademark Office (USPTO).
11/30/2023
The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for Rezurock, a human drug product, in response to a patent extension application submitted to the US Patent and Trademark Office (USPTO).
11/30/2023
The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for Nuzyra Injection, a new drug application submitted to extend a patent claiming the human drug product Nuzyra Injection.
11/30/2023
The Federal Housing Finance Agency is implementing changes to the Enterprise Regulatory Capital Framework to improve risk management for Fannie Mae and Freddie Mac, two government-sponsored enterprises that provide mortgage financing to the US housing market.
11/30/2023
The Consumer Product Safety Commission is seeking public comment on a new information collection to investigate smart toys and additional toys through child observations and caregiver questionnaires, with the goal of updating age determination guidelines.
11/30/2023
The National Institute of Justice will host an in-person workshop to discuss the upcoming transition to NIJ Standard 0101.07, which will replace the current standard, and its impact on the Compliant Products List and Follow-up Inspection Testing of body armor models.
11/30/2023
The National Institute of Justice has published two new standards, NIJ Standard 0101.07 and NIJ Standard 0123.00, which outline the ballistic resistance of body armor and ballistic protection levels, respectively. The NIJ Compliance Testing Program will transition its operations to focus on implementing these new standards.
11/30/2023
The Federal Bureau of Investigation (FBI), in collaboration with the Department of Justice (DOJ), is seeking OMB approval for a proposed information collection related to the Uniform Crime Reporting (UCR) Instrument, following a previously announced 60-day public comment period that began on September 15, 2023.
11/30/2023
The U.S. Department of State has extended the public comment period for the Exchange Visitor Program--Au pair category by 30 days, from December 29, 2023, to January 28, 2024, in response to a request from the Alliance for International Exchange.
11/30/2023
The U.S. government has delegated authority to the Secretary of Commerce to manage the implementation of the Creating Helpful Incentives To Produce Semiconductors (CHIPS) Act of 2022, a law aimed at boosting domestic semiconductor production.
11/30/2023
The U.S. Department of the Treasury is issuing a notice to invite state and local governments to apply for awards under the Social Impact Partnerships to Pay for Results Act, with a focus on projects that benefit children and a total funding of approximately $40.9 million
11/30/2023
The IRS is seeking public input on a proposed collection related to Credit for Small Employer Health Insurance Premiums, as part of its efforts to reduce paperwork and burden, in accordance with the Paperwork Reduction Act of 1995.
11/30/2023
The Financial Crimes Enforcement Network (FinCEN) is extending the deadline for certain companies created or registered in 2024 to file beneficial ownership information reports, giving them more time to comply with the new rule.
11/30/2023
The Federal Emergency Management Agency (FEMA) has issued a public assistance declaration for the state of California following Tropical Storm Hilary, effective from August 19 to 21, 2023.
11/30/2023
The Federal Reserve Board is extending the Survey of Household Economics and Decisionmaking for three years, with revisions, under delegated authority and submitting it to the Office of Management and Budget.
11/30/2023
The Federal Reserve Board has adopted a proposal to extend the Consumer and Stakeholder Surveys for three years without revision, as approved by the Board of Governors.
11/30/2023
The Federal Reserve Board of Governors has approved a three-year extension of the Ad Hoc Clearance for Surveys of Consumer and Community Affairs Publications and Resources, without any revisions, as part of its delegated authority and submission to the Office of Management and Budget (OMB).
11/30/2023
The Federal Trade Commission has announced an updated ten-year schedule for reviewing its rules and guides, clarifying that this does not imply any determination on the need for or substance of the listed rules and guides.
11/29/2023
CBN directs banks to issue and accept old, redesigned Naira banknotes
11/29/2023
The US has updated its National Bioengineered Food Disclosure Standard by adding two new types of bioengineered foods to the list, providing consumers with more information about potentially bioengineered foods and helping regulated entities determine if disclosure is required.
11/29/2023
The US Department of Agriculture has added Bolivia to the list of regions affected by highly pathogenic avian influenza, following restrictions on importing avian commodities from the country due to confirmed HPAI cases.
11/29/2023
The US Department of Agriculture has confirmed the presence of African swine fever in Singapore, prompting the addition of the country to the list of regions affected by the disease, as maintained by the Animal and Plant Health Inspection Service (APHIS).
11/29/2023
The U.S. Food and Drug Administration (FDA) has published a notice determining the regulatory review period for the patent extension of Azstarys, a human drug product, following a submission to the U.S. Patent and Trademark Office (USPTO).
11/29/2023
The U.S. Food and Drug Administration (FDA) has published a notice determining the regulatory review period for Lupkynis, a human drug product, in response to a patent extension application submitted to the U.S. Patent and Trademark Office (USPTO).
11/29/2023
The Food and Drug Administration (FDA) has determined the regulatory review period for Kerendia, a human drug product, and is publishing this notice as required by law. FDA made the determination due to a submission to the U.S. Patent and Trademark Office (USPTO) for patent extension.
11/29/2023
The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for Olinvyk, a human drug product, in response to patent extension applications submitted to the US Patent and Trademark Office (USPTO).
11/29/2023
The FDA has published a notice determining the regulatory review period for Empaveli, a human drug product, following submissions to the USPTO for patent extension.
11/29/2023
The U.S. Food and Drug Administration (FDA) has published a notice stating that it has determined the regulatory review period for Tukysa, a human drug product, in order to extend its patent, following submissions to the U.S. Patent and Trademark Office (USPTO).
11/29/2023
The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for Orgovyx, a human drug product, in response to patent extension applications submitted to the US Patent and Trademark Office (USPTO).
11/29/2023
The U.S. Food and Drug Administration (FDA) has determined the regulatory review period for the patent extension of PYLARIFY, a human drug product, following submissions to the U.S. Patent and Trademark Office (USPTO).
11/29/2023
The Department of the Treasury will submit a request for review and clearance of an information collection activity to the Office of Management and Budget (OMB) in accordance with the Paperwork Reduction Act of 1995, and is seeking public comments on the request.
11/29/2023
The FDIC is adopting a final rule to collect a special assessment of $16.3 billion to recover losses from the protection of uninsured depositors following the closures of Silicon Valley Bank and Signature Bank, with quarterly payments of 3.36 basis points on estimated uninsured deposits.
11/29/2023
The Office of the Comptroller of the Currency (OCC), the Federal Reserve Board, and the Consumer Financial Protection Bureau (CFPB) are finalizing changes to their regulations regarding special appraisal requirements for 'higher-priced mortgage loans' (HPMLs), which are loans with higher risk and are subject to stricter appraisal standards. The changes, effective January 18, 2014, exempt loans of $25,000 or less from these requirements and adjust the exemption threshold annually based on the Consumer Price Index for Urban Wage Earners and Clerical Workers (CPI-W).
11/29/2023
The Federal Reserve Board and the Consumer Financial Protection Bureau are releasing updated regulations for the Truth in Lending Act, which will increase the exemption threshold for certain consumer credit transactions based on the annual percentage increase in the Consumer Price Index for Urban Wage Earners and Clerical Workers, effective January 1, 2024.
11/29/2023
The Consumer Financial Protection Board and the Federal Reserve are updating the rules for consumer leases, increasing the exemption threshold from $66,400 to $69,500 starting January 1, 2024, based on the annual percentage increase in the Consumer Price Index for Urban Wage Earners and Clerical Workers.